Dangerous Drug News

Side Effect Information About Dangerous Drugs and Medical Devices

Altrumedia
  • Home
  • About
  • Dangerous Drug News
  • Drugs
    • Fluoroquinolone Antibiotics
    • Pradaxa
    • Proton Pump Inhibitors
    • Risperdal
    • Talcum Powder
    • Taxotere
    • Xarelto
    • Zofran
  • Medical Devices
    • Essure
    • IVC Filters
    • Power Morcellators
    • Transvaginal Mesh
  • Free Case Evaluation

Zofran

zofran

Zofran (ondansetron) is an antiemetic drug, used to treat and prevent nausea and vomiting. It was the first in a class of drugs called serotonin-3 (5-HT3) receptor antagonists to receive meant to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy and surgery. It is not and never has been approved for use in pregnant women, but for many years it was prescribed off-label to treat nausea and vomiting of pregnancy (NVP).

Zofran Uses

Zofran was approved by the U.S. Food and Drug Administration (FDA) in 1991. It is approved for the following uses:

  • Prevent nausea and vomiting caused by chemotherapy treatment for cancer
  • Prevent nausea and vomiting caused by radiation therapy
  • Prevent post-surgical nausea and vomiting

Zofran Side Effects

The following side effects have been associated with Zofran use:

  • Serotonin syndrome
  • QT prolongation
  • Blurred vision
  • Temporary vision loss
  • Severe dizziness
  • Shortness of breath
  • Difficulty breathing
  • Fainting
  • Fast or pounding heartbeats
  • Slow heart rate
  • Anxiety
  • Agitation
  • Shivering
  • Fainting
  • Seizures
  • Urinating less than usual or not at all
  • Diarrhea
  • Constipation
  • Fever
  • Headache

Serotonin syndrome occurs when high levels of serotonin accumulate in your body. It is a medical emergency and can be life-threatening.

QT prolongation is an electrical disturbance in the heart that can cause serious irregular heart rhythms. It can be fatal.

Zofran Off-Label

The FDA only approves drugs for specific purposes. When a drug is used for any other purpose, it is referred to as “off-label”. Doctors are allowed to prescribe drugs off-label, when they feel it is in the best interests of their patients. Drug companies, on the other hand, are not allowed to market their products for off-label purposes.

Zofran is sometimes prescribed off-label to treat acute gastroenteritis in children.

For many years, Zofran was also prescribed off-label to treat morning sickness in pregnant women. In 2012, the manufacturer reached a settlement agreement with the government regarding the marketing of several pharmaceutical products. There were no findings that the manufacturer illegally marketed Zofran and the manufacturer did not admit wrongdoing or agree to plead guilty with respect to the marketing of Zofran.

Dangers of Zofran Use in Pregnancy

Zofran use during pregnancy can cause harm to the fetus and birth defects including:

  • Fetal death
  • Fetal growth restriction
  • Congenital heart malformations
  • Hypospadias
  • Heart murmurs
  • Orofacial clefts
  • Skeletal abnormalities
  • Skull deformities
  • Kidney malformation
  • Jaundice
  • Clubbed foot
  • Vision problems
  • Hearing loss

If you have questions about Zofran that are not answered here or believe your child’s birth defect was caused by Zofran, please email us.  We will help you find answers to your questions and we can refer you to an attorney who represents families of children with birth defects.

Share this:

  • Facebook
  • LinkedIn
  • Twitter

RSS FDA Med Watch

  • 2023 Safety Communications
  • Evaluation of Safety Concerns with Certain Dental Devices Used on Adults – FDA Safety Communication
  • Jarman’s Midwest Cleaning Systems, Inc. Issues Voluntary Nationwide Recall of Alcohol Antiseptic 80% Topical Solution Hand Sanitizer Non-sterile Solution and Isopropyl Alcohol Antiseptic 75% Topical Solution Hand Sanitizer Non-sterile Solution Due to Presence of Methanol
  • Risks with Exactech Joint Replacement Devices with Defective Packaging – FDA Safety Communication
  • Ascend Laboratories LLC. Issues Voluntary Nationwide Recall of Dabigatran Etexilate Capsules, USP 75 mg and 150 mg, Due to the Detection of N-Nitroso-dabigatran (NDAB) Impurity
  • UPDATE: Reports of Squamous Cell Carcinoma (SCC) in the Capsule Around Breast Implants - FDA Safety Communication
  • 2023 Medical Device Recalls

Recent Headlines

Diabetic Man Testing Blood Levels

Type 2 Diabetes Drugs Pose Numerous Health Risks

The hits just keep coming for Johnson & Johnson, and now its … [Read More...]

PPIs Side Effects

PPI Heartburn and Ulcer Medications May Cause Stomach Cancer

Proton pump inhibitors (PPIs) are used to treat heartburn, … [Read More...]

Johnson & Johnson Loses Second Major Talcum Powder Case

In its second trial loss in less than 3 months, Johnson & … [Read More...]

Find an Attorney

RSS US Recall News

  • Belviq Withdrawn Due to Cancer Risk
  • Common Heartburn Medication may lead to bladder, stomach, and other cancers. Zantac Lawsuits begin.
  • J&J Settles Talc Mesothelioma Settlement

RSS Lawsuits and Settlements

  • Possible Lawsuit: CPAP Lung Cancer Lawsuit News and Legal Information
  • Possible Lawsuit: Birth Injury and Birth Defect Lawsuit News and Legal Information
  • Possible Lawsuit: Wyoming Medical Malpractice Lawsuit News & Legal Information

RSS Mass Tort News

RSS Health Industry

  • BREAKING: Gwyneth Paltrow Cleared In $3M Ski Crash Trial
  • Ex-CEO Whistleblower Nets $12M In Hospital's $69M FCA Deal
  • BREAKING: Trump Charged In Sealed NY Indictment

ABOUT US

DRUG INFO

DEVICES

CASE REVIEW

NEWS

Copyright © 2023 DangerousDrugNews.com · Site Map - Website Development by Altrumedia · Log in